Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Neurobiological Technologies, Inc. (NASDAQ: NTII)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Premium News
Press Releases
SEC
Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share
Nov 23, 2009 08:01 AM |
NTII
Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution
Oct 28, 2009 09:02 AM |
NTII
Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market
Oct 19, 2009 04:20 PM |
NTII
Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification
Sep 17, 2009 05:00 PM |
NDAQ
,
NTII
NTII Faces Shareholder Pressure to Liquidate
Jan 14, 2009 11:42 AM |
NDAQ
,
NTII
Neurobiological Technologies Sets Date for Third Quarter Financial Results and GATTEX(TM) Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session and GATTEX(TM) Abstracts Accepted for Presentation at DDW Conference; Phase 3 Short Bowel Syndrome Results Scheduled for Oral Plenary Session
May 08, 2008 11:29 AM |
ARTE
,
NPSP
,
NTII
More..
Area Stocks Outperform Market Indexes
Mar 31, 2009 11:02 PM |
NTII
,
PMI
,
SNX
,
XTNT
,
ZHNE
More..
Neurobiological Technologies Announces Board Approval of Plan of Liquidation and Dissolution
Aug 31, 2009 04:55 PM |
NTII
Neurobiological Technologies Announces Board Approval of Plan of Liquidation and Dissolution ; Company Also Announces Termination of Rights Plan and Reports Fourth Quarter and Fiscal Year-End Financial Results for 2009
Aug 31, 2009 02:57 PM |
NTII
Neurobiological Technologies Announces Termination of its License and Cooperation Agreement with Merz and Children's Medical Center
Aug 12, 2009 08:31 AM |
NTII
Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
Jun 01, 2009 08:31 AM |
NTII
Tang Capital Partners, LP and Perceptive Life Sciences Master Fund Ltd. Urge the Shareholders of Penwest Pharmaceuticals Co. To Vote for Their Shareholder Proposals
May 15, 2009 10:14 AM |
APPA
,
GENZ
,
NTII
,
PPCO
,
RDEA
Neurobiological Technologies Reports Third Quarter Fiscal 2009 Financial Results
May 08, 2009 07:54 AM |
NTII
Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
May 01, 2009 07:01 AM |
NTII
Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company
Mar 26, 2009 07:31 AM |
NTII
Neurobiological Technologies Reports Second Quarter Fiscal 2009 Financial Results
Feb 12, 2009 04:30 PM |
NTII
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Feb 04, 2009 07:01 AM |
NTII
More..
Form 4 COHEN ABRAHAM E For: Nov 06 (10K)
Nov 09, 2009 05:12 PM
Form 4 NEUROBIOLOGICAL TECHNOLO For: Oct 22 Filed by: Heslop Ryan (10K)
Oct 26, 2009 07:01 PM
Form 3 NEUROBIOLOGICAL TECHNOLO For: Oct 21 Filed by: Warszawski Ariel (10K)
Oct 26, 2009 03:42 PM
Form 4 NEUROBIOLOGICAL TECHNOLO For: Oct 21 Filed by: BVF INC/IL (10K)
Oct 23, 2009 06:40 PM
Form 4 FREIMAN PAUL E For: Dec 10 (10K)
Feb 12, 2009 09:29 PM
Form 4 NEUROBIOLOGICAL TECHNOLO For: Nov 14 Filed by: J P MORGAN CHASE & CO (10K)
Nov 18, 2008 02:37 PM
Form 4 COHEN ABRAHAM E For: Nov 13 (10K)
Nov 17, 2008 02:11 PM
Form 4 Fletcher William A For: Nov 13 (10K)
Nov 17, 2008 02:06 PM
Form 4 KASPER F VAN For: Nov 13 (10K)
Nov 17, 2008 02:06 PM
Form 4 NEUROBIOLOGICAL TECHNOLO For: Nov 13 Filed by: SOFAER ABRAHAM D (10K)
Nov 17, 2008 02:06 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
NTII
Compare to S&P
YTD
-26.16 %
-38.89 %
4 Weeks
-74.71 %
-74.98 %
12 Weeks
-72.08 %
-73.68 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
5,400.00 %
EPS Growth in Last Year:
507.69 %
Sales Growth in Last Quarter:
440.36 %
Sales Growth in Last Quarter:
363.45 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
